By Assoc. Prof. Dr. Mehmet Sorar | Published: 05.02.2025
Overview of Parkinson Plus Disease
Parkinson Plus is a popular name for progressive conditions in which Parkinson-like movement problems, such as slowness, stiffness and poor balance, come with other features. Medical writing calls the group atypical parkinsonism. It includes multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration and dementia with Lewy bodies. No treatment is known to stop them, and care focuses on symptoms.
Which conditions does Parkinson Plus include?
Four conditions are described here, and each has its own name, usual age at onset and hallmark features. They are separate diagnoses, not stages of one disease.
- Multiple system atrophy (MSA): Cleveland Clinic describes a rare disease that affects movement and automatic body functions such as blood pressure, bladder and breathing. It comes in two types: MSA-P, with parkinsonism, and MSA-C, with loss of balance and coordination (ataxia). It most often starts between 50 and 59, and men and women are equally affected.
- Progressive supranuclear palsy (PSP): The NHS describes a rare condition affecting balance, movement, eye control, speech and swallowing. Most cases develop after age 60.
- Corticobasal degeneration (CBD): The NHS says it is rare and most often starts between 50 and 70. It often begins with difficulty controlling one limb, usually on one side first.
- Dementia with Lewy bodies (DLB): The NHS describes a dementia caused by protein clumps called Lewy bodies. It is rare under 65 and usually worsens slowly over several years.
Cleveland Clinic gives about 0.6 to 0.7 new MSA cases per 100,000 people a year, and about 3.4 to 4.9 people per 100,000 living with it. The symptoms of each condition are set out on What is Parkinson Plus, early symptoms and daily life.
How do these conditions compare with Parkinson's disease?
They can look alike early on, but medicine response and the evidence for advanced treatments differ. Cleveland Clinic says MSA is often first mistaken for Parkinson's disease. The table sets the main points side by side; Parkinson's disease itself is described on What is Parkinson's disease?.
| Topic | In Parkinson Plus conditions |
|---|---|
| Early picture | Can resemble Parkinson's disease. MSA is often first mistaken for it (Cleveland Clinic), and PSP and CBD are diagnosed after Parkinson's disease is ruled out (NHS) |
| Levodopa, the main Parkinson's medicine | Works less well in MSA than in Parkinson's disease (Cleveland Clinic) |
| Treatment that stops progression | None known for MSA, PSP or CBD, and none proven to slow DLB (Cleveland Clinic, NHS) |
| Deep brain stimulation (DBS) | Established for advanced Parkinson's disease, but evidence does not support it in atypical parkinsonism (Artusi and colleagues) |
| Transcranial magnetic stimulation (TMS) | Research is preliminary, and large double-blind trials are missing (Petsani and colleagues) |
What causes these conditions, and are they inherited?
The causes are not fully known, but each condition is linked to protein deposits in the brain. Cleveland Clinic says the cause of MSA is unknown and suspects a protein called alpha-synuclein plays a role. The NHS links PSP to clumps of tau protein in certain brain areas, and CBD to tau clumps in the cortex and basal ganglia. DLB comes from Lewy bodies, the same deposits seen in Parkinson's disease, though DLB is a separate diagnosis whose main feature is dementia.
Inheritance appears to play a small role. The NHS says some genetic changes are linked to PSP but are not inherited as such, and the risk to relatives is very low. For CBD it says genetic links are weak. Inheritance in DLB is not covered here, so ask the doctor if it concerns your family. Why the proteins begin to collect is not fully understood.
How are they diagnosed?
No single test confirms any of them. The NHS says PSP and CBD are diagnosed from the pattern of symptoms after other conditions, such as Parkinson's disease and, for CBD, stroke, have been ruled out, with brain scans and memory or language tests as needed. For DLB the assessment includes a symptom review, mental ability tests, blood tests to rule out other causes and brain scans (MRI, CT or SPECT).
Cleveland Clinic says a definite diagnosis of MSA needs examination of brain tissue after death, so in life the diagnosis rests on symptoms, history and a poor response to levodopa. An MRI sign called the hot cross bun sign may appear in MSA-C, but other conditions can also cause it. The criteria doctors use are explained on Parkinson Plus treatment doctor, how to choose and what to ask.
How are they treated, and where do TMS and DBS stand?
Treatment manages symptoms. Petsani and colleagues write that these conditions have varied symptoms and no disease-modifying treatments (treatments that change the course of the disease), so care is mainly symptomatic. The NHS names, for example:
- PSP: medicines for stiffness, physiotherapy, speech and language therapy, occupational therapy, botulinum toxin or special glasses for eye problems, and a feeding tube for severe swallowing difficulty
- CBD: medicines for stiffness, spasms, sleep, mood, pain or memory, plus therapies and palliative care
- DLB: medicines for hallucinations, confusion, drowsiness, movement and sleep problems, plus physiotherapy, occupational therapy, speech therapy and cognitive stimulation
For TMS, Petsani and colleagues say most reviewed studies reported benefit on movement and non-movement symptoms, but the evidence is preliminary. The studies and their limits are on Parkinson Plus and TMS. For DBS, Artusi and colleagues found 25 studies covering 66 people with atypical parkinsonism. Only three were randomised controlled trials and most had a high risk of bias, and the authors conclude that current evidence does not support DBS here. Neither method is an established option for these conditions.
How care is arranged is covered on Parkinson Plus treatment, the care process.
Which signs should prompt a neurological assessment?
Ask for an assessment when Parkinson-like symptoms come with signs that point elsewhere. Examples include frequent falls and trouble controlling eye or eyelid movements (NHS, PSP), low blood pressure on standing (Cleveland Clinic, MSA), visual hallucinations and faints (NHS, DLB), and a poor response to levodopa.
Some problems should not wait. The NHS says swallowing problems in CBD can cause pneumonia, which can be life-threatening, and Cleveland Clinic lists pneumonia and a urinary infection that spreads to the blood (sepsis) among common causes of death in MSA. Choking, a cough with fever, breathlessness, fainting or a serious fall need prompt medical attention, and choking that does not clear or severe breathlessness is an emergency.
Sources
- Cleveland Clinic: Multiple System Atrophy (MSA)
- NHS: Progressive supranuclear palsy (PSP)
- NHS: Corticobasal degeneration
- NHS: Dementia with Lewy bodies
- Petsani and colleagues, Therapeutic Application of rTMS in Atypical Parkinsonian Disorders (2021)
- Artusi and colleagues, Deep brain stimulation for atypical parkinsonism: A systematic review on efficacy and safety (2022)
This article is for general information and does not replace medical diagnosis or treatment. Please consult your physician for advice about your own condition.
Assoc. Prof. Dr. Mehmet Sorar
Neurosurgeon in Ankara. Graduated from Gazi University Faculty of Medicine in 1997, specialist since 2004, associate professor since 2019. Full CV
Related treatment page: Parkinson Plus